EUR/USD Signal Update Yesterday’s signals were not triggered as the price never reached 1.1337. Today’s EUR/USD Signals Risk 0.75% Trades must be taken from 8am until 5pm London time today only. Long Trade 1 Long entry following a bullish price action reversal on the H1 time frame immediately upon the next touch of 1.1337. Put the…
This is how it usually goes: a stock or a sector rises, catches the attention of the masses, gets into a euphoria phase … and right at the moment when everyone thinks the world has changed because of that company or sector it all comes down like a house of cards. And when nobody pays attention anymore…
Gold settled slightly lower on Monday as investors continue to digest last week’s strong employment data and the cautious tone of Fed Chair Janet Yellen over raising interest rates. Although Yellen is not in such a hurry to normalize policy, some of her colleagues are ready to raise rates for the second time. Federal Reserve…
by Barkley Rosser (Econospeak) Aggregate housing prices in the US have recently been approaching the levels seen at the peak of the housing bubble back in 2006.Indeed, in some locations they have gone higher than they did then, such as in San Francisco.This has led some to speculate that the US is getting back into a housing bubble…
Written by Frank Holmes, CEO Of U.S. Global Investors The last time gold had a quarter this strong, Ronald Reagan was a year into his second term as president, the Soviet Union was taking its final gasp and the U.S. was still reeling from the Challenger explosion. In the first quarter, the yellow metal rose 16.5 percent,…
The Reserve Bank of Australia left the interest rate unchanged at 2%, as widely expected. What stands out is that the RBA sees the rise of the currency as at least partially reflecting the higher commodity prices. In general, a further appreciation would “complicate” things, but they certainly do not see worried at the moment. AUD/USD, which…
After a lackluster start to 2016, Pfizer’s (PFE) stock price is currently trending upwards, albeit at a slow pace. The performance of Pfizer according to a historical stock chart indicates a clear downward trend from May 2015 all the way through to February 2016. However, a reversal appears to be taking place with bullish momentum…
The RBA’s monetary policy meeting today saw the key rates left unchanged at 2.0%. The RBA cut interest rates in May 2015 and has left rates unchanged since then. However, the focus of today’s monetary policy meeting was the recent appreciation in the exchange rate of the Australian dollar leading many to speculate on the…
Biotechnology is one of those sectors that is totally out of grace after it came down sharply in the second half of 2015, as market volatility rose sharply. The first chart shows that the biotech index (represented by the IBB ETF) lost 40% of its value in just 7 months. Talking about a sharp correction! That could…
Aeglea Biotherapeutics Inc. (AGLE) expects to raise $51.4 million in its upcoming IPO. Based in Austin, Texas, Aeglea Biotherapeutics is a biotechnology company developing enzyme-based therapeutics to treat disorders of metabolism and cancer. AGLE will offer 3.5 million shares at an expected price range of $16 to $18. CRVS filed for the IPO on June 16, 2015….
